| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/30/2009 | EP2137152A1 Novel benzamide derivatives and process for the preparation thereof |
| 12/30/2009 | EP2136825A2 Use of lactobacillus plantarum for increasing bacterial diversity |
| 12/30/2009 | EP2136793A2 Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 12/30/2009 | EP1530642B1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 12/30/2009 | EP1501498B1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 12/30/2009 | EP1307108B1 Oil/fat composition |
| 12/30/2009 | CN201370888Y Multifunctional medicated pad |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/30/2009 | CN100574804C A composition for treating gastrointestinal disorder |
| 12/30/2009 | CN100574793C Medicament containing ranitidine |
| 12/30/2009 | CN100574790C Medicine composition for preventing and treating peptic ulcer |
| 12/30/2009 | CN100574786C A tortoise preparation and its production technology |
| 12/30/2009 | CN100574784C Orally taken traditional Chinese medicine composition for treating bacillary dysentery |
| 12/30/2009 | CN100574775C Rabdosia serra (Maxim.) hara extract, preparing process and application thereof |
| 12/30/2009 | CN100574768C An anticancer medicinal composition, preparing method and use thereof |
| 12/30/2009 | CN100574764C Anti-hepatitis pharmaceutical composition and preparation process thereof |
| 12/30/2009 | CN100574759C Method for preparing lansoprazole intestine dissolving capsule |
| 12/30/2009 | CN100574630C Low-salinity autumn and winter cultivation ecological bait for litopenaeus vannamei and its preparation method |
| 12/30/2009 | CA2765298A1 Probiotic bacterial molecules and their use in methods to treat/prvent infection by harmful bacteria and to provide nutritional health |
| 12/30/2009 | CA2728391A1 Composition and method for enhancing fluoride uptake using bioactive glass |
| 12/30/2009 | CA2728161A1 Therapeutic agent for inflammatory bowel disease |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
| 12/29/2009 | US7638535 (3S)-trans)-8-methyl-3,4-dihydro-2H-benzo[b][1,4]dioxepine-6-carboxylic acid [3-hydroxy-1-(3-methoxy-propyl)-piperidin-4-ylmethyl]-amide; hypermotility, irritable bowel syndrome, constipation or diarrhea predominant IDS, pain and non-pain predominant IBS and bowel hypersensitivity |
| 12/29/2009 | US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound |
| 12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638490 For treating anorexia or cachexia |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638335 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 12/29/2009 | US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 12/29/2009 | US7638129 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 12/29/2009 | CA2480125C Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone |
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2425215C Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/29/2009 | CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them |
| 12/29/2009 | CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels |
| 12/29/2009 | CA2304948C Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 12/26/2009 | CA2670659A1 Method for the production of a plant-based medicament |
| 12/24/2009 | US20090318524 Bicyclic tetrahydropyrrole compounds |
| 12/24/2009 | US20090318503 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318365 Metastin derivatives and use thereof |
| 12/24/2009 | US20090317498 Composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 12/24/2009 | US20090317461 Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds |
| 12/24/2009 | US20090317427 Zwitterionic Polysaccharides for Promotion of Immune System Maturation and Health |
| 12/24/2009 | US20090317371 Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases |
| 12/24/2009 | DE202008015430U1 Zusammensetzung zur Behandlung von Verdauungsstörungen Composition for the treatment of digestive disorders |
| 12/23/2009 | WO2009155054A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 12/23/2009 | WO2009154810A2 Delivery systems for multiple active agents |
| 12/23/2009 | WO2009154248A1 Pharmaceutical composition for treatment or prevention of hbv infection |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009154132A1 Spirodiamine-diarylketoxime derivative |
| 12/23/2009 | WO2009153960A1 Glycosylated glp-1 peptide |
| 12/23/2009 | WO2009153182A1 Novel heteroaryl carboxamide derivatives |
| 12/23/2009 | WO2009132048A3 Treating eosinophilic esophagitis |
| 12/23/2009 | WO2009115321A8 Imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 12/23/2009 | EP2135866A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis |
| 12/23/2009 | EP2135858A1 Composition for teating infectious diseases |
| 12/23/2009 | EP2135616A1 Dried bilberries for influencing intestinal conditions |
| 12/23/2009 | EP2135614A1 Intestinal dismicrobism compound having anti-diarrhoea, anti-inflammatory and lactose and lactose derivative intolerance lenitive properties |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/23/2009 | EP2134347A2 Compositions and methods for preventing and treating mucositis and weight loss |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1164874B1 Use of negatively charged, non-digestible polysaccharide hydrolysates for reducing transport through tight junctions of the intestin |
| 12/23/2009 | CN101610812A Treatment of faecal incontinence |
| 12/23/2009 | CN101610779A 5ht4受体拮抗药 5ht4 receptor antagonist |
| 12/23/2009 | CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 12/23/2009 | CN101610754A Pharmaceutical composition containing fine particle oil-based suspension |
| 12/23/2009 | CN101610688A Polyphenol extraction process |
| 12/23/2009 | CN101610682A Method of preventing diseases in piglings in the weaning stage |
| 12/23/2009 | CN101608155A Kidney-invigorating health-care wine |
| 12/23/2009 | CN101607086A Compound bismuth composition and preparation method thereof |
| 12/23/2009 | CN101607077A Traditional Chinese medicine composition for treating vertigo and preparation method thereof |
| 12/23/2009 | CN101607075A Oral solution capable of sweating and expelling toxin |
| 12/23/2009 | CN101607074A Medicinal composition for treating chronic gastritis and preparation method thereof |
| 12/23/2009 | CN101607071A Medicine for treating chronic hepatitis B and preparation method thereof |
| 12/23/2009 | CN101607068A Traditional Chinese medicine pro-liposome injection for treating liver cancer and preparation process thereof |
| 12/23/2009 | CN101607067A Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof |
| 12/23/2009 | CN101607066A Chinese medicinal composition for reducing cholesterol and triglycercide |
| 12/23/2009 | CN101607065A Medicinal composition for treating liver-depression spleen-insufficiency type fatty liver |
| 12/23/2009 | CN101607064A Medicinal composition for replenishing qi, strengthening spleen, transforming stasis and freeing vessels and preparation method thereof |
| 12/23/2009 | CN101607063A Medicinal composition for lowering fat and protecting liver and preparation method thereof |
| 12/23/2009 | CN101607062A Chinese traditional medicine composition for treating recurrent oral ulcer |
| 12/23/2009 | CN101607061A Medicinal composition for protecting gastric mucosa and preparation method thereof |
| 12/23/2009 | CN101607053A Manufacturing method for Children stasis relieving and digestion promoting oral liquid |
| 12/23/2009 | CN101607052A Medicinal composition for treating chronic atrophic gastritis and preparation method thereof |